GO
Loading...

Health Care Equipment

More

  • Midday Glance: Medical Devices companies Monday, 14 Apr 2014 | 2:08 PM ET

    Allergan rose $3.06 or 2.5 percent, to $123.95. Baxter International Inc. rose$. 79 or 1.1 percent, to $72.77. Boston Scientific Corp. rose$. 51 or 4.0 percent, to $13.20.

  • April 14- Shares of medical device maker Medtronic Inc fell as much as 6 percent after a U.S. court temporarily halted sales of its aortic heart valve replacement system in the country.

  • Early Glance: Medical Devices companies Monday, 14 Apr 2014 | 10:21 AM ET

    Allergan rose$. 47 or. 4 percent, to $121.36. Baxter International Inc. rose$. 47 or. 7 percent, to $72.45. Boston Scientific Corp. rose$. 48 or 3.8 percent, to $13.17.

  • Final Glance: Medical Devices companies Friday, 11 Apr 2014 | 6:03 PM ET

    Allergan rose $4.26 or 3.7 percent, to $120.89. Baxter International Inc. fell$. 28 or. 4 percent, to $71.98. Boston Scientific Corp. fell$. 24 or 1.9 percent, to $12.69.

  • Midday Glance: Medical Devices companies Friday, 11 Apr 2014 | 1:51 PM ET

    Allergan rose $4.38 or 3.8 percent, to $121.00. Baxter International Inc. rose$. 15 or. 2 percent, to $72.41. Boston Scientific Corp. fell$. 32 or 2.4 percent, to $12.62.

  • Early Glance: Medical Devices companies Thursday, 10 Apr 2014 | 10:24 AM ET

    Allergan fell $1.17 or 1.0 percent, to $119.74. Baxter International Inc. fell$. 37 or. 5 percent, to $73.08. Boston Scientific Corp. fell$. 18 or 1.3 percent, to $13.36.

  • Final Glance: Medical Devices companies Wednesday, 9 Apr 2014 | 6:06 PM ET

    Allergan rose $3.00 or 2.5 percent, to $120.91. Baxter International Inc. rose $1.15 or 1.6 percent, to $73.45. Boston Scientific Corp. rose$. 63 or 4.9 percent, to $13.54.

  • Midday Glance: Medical Devices companies Wednesday, 9 Apr 2014 | 1:15 PM ET

    Allergan rose $1.95 or 1.7 percent, to $119.86. Baxter International Inc. rose$. 62 or. 9 percent, to $72.92. Boston Scientific Corp. rose$. 47 or 3.6 percent, to $13.38.

  • Early Glance: Medical Devices companies Tuesday, 8 Apr 2014 | 10:43 AM ET

    Allergan fell$. 65 or. 5 percent, to $120.13. Baxter International Inc. rose$. 24 or. 3 percent, to $72.73. Boston Scientific Corp. fell$. 17 or 1.3 percent, to $13.05.

  • Final Glance: Medical Devices companies Monday, 7 Apr 2014 | 6:01 PM ET

    Allergan fell $3.35 or 2.7 percent, to $120.77. Baxter International Inc. fell$. 44 or. 6 percent, to $72.49. Boston Scientific Corp. fell$. 28 or 2.1 percent, to $13.22.

  • Midday Glance: Medical Devices companies Monday, 7 Apr 2014 | 1:50 PM ET

    Allergan fell $3.31 or 2.7 percent, to $120.81. Baxter International Inc. rose$. 06 or. 1 percent, to $72.99. Boston Scientific Corp. fell$. 15 or 1.1 percent, to $13.35.

  • Final Glance: Medical Devices companies Friday, 4 Apr 2014 | 6:19 PM ET

    Allergan fell $1.26 or 1.0 percent, to $124.12. Baxter International Inc. fell$. 46 or. 6 percent, to $72.93. Boston Scientific Corp. fell$. 27 or 2.0 percent, to $13.50.

  • Midday Glance: Medical Devices companies Friday, 4 Apr 2014 | 1:20 PM ET

    Allergan fell$. 24 or. 2 percent, to $125.14. Baxter International Inc. rose$. 26 or. 3 percent, to $73.64. Boston Scientific Corp. fell$. 21 or 1.5 percent, to $13.57.

  • Early Glance: Medical Devices companies Friday, 4 Apr 2014 | 10:57 AM ET

    Allergan rose$. 66 or. 5 percent, to $126.04. Baxter International Inc. rose$. 24 or. 3 percent, to $73.63. Boston Scientific Corp. rose$. 08 or. 6 percent, to $13.85.

  • WASHINGTON, March 30- A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year of follow-up observation, in line with favorable results seen in original clinical trials of the Medtronic Inc product.

  • WASHINGTON, March 30- A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year of follow-up observation, in line with favorable results seen in original clinical trials of the Medtronic Inc product.

  • WASHINGTON, March 30- The minimally invasive aortic heart valve replacement system from Edwards Lifesciences Corp performed better than a rival product sold by Medtronic Inc in the first head-to-head study of the two, according to data from a small German trial presented at a major heart meeting on Sunday.

  • March 27- Alimera Sciences Inc said it has applied a fourth time for U.S. regulatory approval to start selling an eye implant that delivers a drug to treat a form of blindess in diabetes patients. The FDA asked for a new trial of the drug-device combination, but Alimera's partner, Psivida Corp, said that additional trials were not necessary.

  • Gates Foundation fighting dirty water deaths Monday, 24 Mar 2014 | 2:15 PM ET
    An exhibitor demonstrates the use of a toilet tap where water is recycled and reused, during the Reinvent The Toilet Fair in New Delhi on March  21, 2014.

    The Gates Foundation has awarded $2 million in grants to several Indian organizations to help improve sanitation by building a high-tech toilet.

  • March 14- Medical device maker Hologic Inc appointed a former Johnson& Johnson executive as chief operating officer, three months after naming a new chief executive as part of a deal with activist investor Carl Icahn.

Most Popular Video

Wednesday, 16 Apr 2014 | 3:00 AM ET

European shares opened higher on Wednesday as better-than-expected Chinese growth data buoyed sentiment.

Wednesday, 16 Apr 2014 | 2:00 AM ET

Brady Dougan, CEO of Credit Suisse, says the bank's fixed income business is "strong", while the investment banking arm has performed well.

Tuesday, 15 Apr 2014 | 7:31 PM ET

Hiroshi Miyoshi, Mitsubishi CEO for Turkey and Central Asia, describes Turkey's appeal to Japanese firms, who invested $500 million in the emerging market last year.